The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.
Ishida T; Ishii T; Inagaki A; Yano H; Kusumoto S; Ri M; Komatsu H; Iida S; Inagaki H; Ueda R; Leukemia, 2006, vol. 20, issue 12, p 2162, ISSN 08876924. ISBN 08876924.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef